Mirae Asset Global Investments’s Cabaletta Bio CABA Stock Holding History

Mirae Asset Global Investments’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.7K	Buy	7,292 +2,271	+45%	+$7.47K	﹤0.01%	1474
2026 Q1	$13.5K	Buy	5,021 +343	+7%	+$952	﹤0.01%	1469
2025 Q4	$10.2K	Buy	+4,678	New	+$11.6K	﹤0.01%	1600
2024 Q4	–	Sell	-1,767	Closed	-$7.53K	–	1603
2024 Q3	$7.53K	Buy	1,767 +326	+23%	+$1.89K	﹤0.01%	1508
2024 Q2	$10.6K	Sell	1,441 -10,539	-88%	-$129K	﹤0.01%	1459
2024 Q1	$204K	Sell	11,980 -11,709	-49%	-$251K	﹤0.01%	2252
2023 Q4	$538K	Buy	23,689 +6,891	+41%	+$116K	﹤0.01%	1927
2023 Q3	$256K	Buy	16,798 +3,798	+29%	+$51.9K	﹤0.01%	2203
2023 Q2	$168K	Buy	+13,000	New	+$141K	﹤0.01%	2392

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mirae Asset Global Investments's CABA Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Cabaletta Bio (CABA) stake by 45% in Q2 2026, buying an estimated $7.47K and bringing the position to 7,292 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Mirae Asset Global Investments first reported a position in CABA in Q2 2023 and has held it in 9 quarters since. The position peaked at $538K in Q4 2023. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Mirae Asset Global Investments held 7,292 shares of Cabaletta Bio worth $22.7K as of Q2 2026.
Mirae Asset Global Investments bought 2,271 Cabaletta Bio shares in Q2 2026, an estimated $7.47K.
Cabaletta Bio made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1474 holding.
Mirae Asset Global Investments first reported a position in Cabaletta Bio in Q2 2023 and has held it in 9 quarters since.
Mirae Asset Global Investments's Cabaletta Bio position peaked at $538K in Q4 2023.
139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.